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A B S T R A C T
Lactobacillus genus includes both probiotic and representative strains of the human gut microbiota. Independent
studies have reported on the anti-inﬂammatory properties of diﬀerent Lactobacillus strains, although we are far
from understanding the underlying molecular interplay. In this work we show that a daily administration of
Lactobacillus acidophilus DSM20079T (DSM20079) to healthy piglets resulted in plasmatic increases of the anti-
inﬂammatory IL10, whilst IL12 and the pro-inﬂammatory ratio IL12+TNFα/IL10 decreased. The extracellular
protein fraction of DSM20079 was identiﬁed as the responsible for the crosstalk interaction that elicited these
tolerogenic eﬀects. This strain was able to activate innate immune pathways in dendritic cells and to decrease
the production of pro-inﬂammatory cytokines in both CD4+/CD8+ T cell subsets in healthy donors and in
Crohn’s Disease patients. The tolerogenic eﬀect exerted by the extracellular proteins of this strain suggests their
potential use as coadjutant for therapeutic applications targeting chronic inﬂammatory illnesses.
1. Introduction
The gastrointestinal (GI) tract encloses a broad community of mi-
croorganisms that co-evolved with the human being to provide the
metabolic and physiological functions that otherwise would not be
fulﬁlled (Walter & Ley, 2011). Alterations in the gut microbiota, named
as dysbiosis, are associated with several illnesses, being the in-
ﬂammatory bowel disease (IBD) one of the best examples. The aberrant
immune response in IBD patients to the gut microbes seems to be re-
lated to its onset, development, persistence and aggressiveness (Willing
et al., 2009). In Crohńs Disease (CrD), one of the main IBD types, cer-
tain bacterial species such as the butyrate-producing bacteria
Faecalibacterium praustnizii, are under-represented in the fecal micro-
biota (Maslowski et al., 2009).
Bacterial extracellular proteins have been proposed as important
players in the molecular dialogue between prokaryotes and the host
(Johnson et al., 2016). In probiotic bacteria, extracellular proteins
mediate important health-promoting mechanisms such as competitive
exclusion of pathogens, enhancement of intestinal barrier function and
modulation of gut mucosal immunity (Lebeer, Vanderleyden, & De
Keersmaecker, 2010). Lactobacillus acidophilus NCFM is a widely used
probiotic strain with an extensive clinical record supporting its health-
promoting properties (Sanders & Klaenhammer, 2001). Several surface-
associated molecules of this strain have been related with its probiotic
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traits, including lipoteichoic acid (Mohamadzadeh et al., 2011), sor-
tase-dependent proteins (Call, Goh, Selle, Klaenhammer, & O’Flaherty,
2015), aggregation promoting factor (Goh & Klaenhammer, 2010) and
a myosin-cross reactive protein (O’Flaherty & Klaenhammer, 2010).
Remarkably the Surface layer A protein (SlpA) of this bacterium, which
is not covalently bound to the cell wall peptidoglycan, is also of interest
to the understanding of how L. acidophilus interacts with the gastro-
intestinal mucosa (Johnson et al., 2016).
In the present work, we describe how a daily administration of L.
acidophilus DSM 20079T to healthy piglets increased the production of
the anti-inﬂammatory cytokine IL10 in plasma, and decreased the pro-
inﬂammatory response of peripheral blood mononuclear cells (PBMCs).
Finally, we used PBMCs from a cohort of Crohn’s Disease patients and
healthy donors to probe that the homeostatic eﬀect mediated by the
extracellular protein fraction is based on the modulation of the innate
immune cells and a reduction in the levels of response of the major T
cell groups. The use of probiotic-derived fractions rather than living
cells is proposed as a therapeutic application.
2. Material and methods
2.1. Ethics
All procedures were approved by the Animal research ethics
Committee of Principado de Asturias, Spain, (reference number PROAE-
12/2018). Experiments were conducted in accordance with the current
Spanish and European legal requirements and guidelines regarding
experimentation and Animal Welfare.
Ethics approval for this study (reference code AGL2013-44039-R
and PS2016) was obtained from the Regional Ethics Committee for
Clinical Research in compliance with the Declaration of Helsinki.
Samples used in this study were obtained from anonymous donors of
the regional blood donation system and from a cohort of Crohn’s
Disease (CD) patients. Location and phenotype of the disease were both
deﬁned according to the Montreal classiﬁcation and the EpidemIBD
protocol (Chaparro et al., 2019).
2.2. Bacterial strain and growth conditions
The strains used in this study were obtained from the stock collec-
tion of the “Instituto de Productos Lácteos de Asturias” (IPLA-CSIC).
The strain Biﬁdobacterium longum subsp. longum NCIMB 8809 was
routinely cultivated in MRS (Difco, BD, Biosciences, San Diego, CA)
containing 0.25% L-cysteine-HCl (Sigma, St. Louis, MO) at 37 °C under
anaerobic conditions (80% N2, 10% CO2, 10% H2) in an MG500
chamber (Don Whitley Scientiﬁc, West Yorkshire, UK). The strains
Lactobacillus acidophilus DSM20079T and Lactobacillus rhamnosus GG
were cultivated in MRS at 37 °C under aerobic conditions in batch
cultures.
2.3. Extracellular protein extraction
Extracellular proteins were obtained from bacterial supernatants
following the protocol described by Sánchez, Chaignepain, Schmitter,
and Urdaci (2009). Samples were ﬁnally centrifuged (16,000g, 21 °C,
5min) to precipitate non solubilized proteins and volumes of 15 µl were
loaded in polyacrylamide gels (12.5%) under denaturing conditions
(SDS-PAGE). Extracellular proteins were separated according to
Laemmli (1970), in an electrophoresis buﬀer containing SDS (1 g/L),
TRIS (3 g/L) and glycine (15 g/L) (Sigma-Aldrich) at pH=8.7, under a
constant current of 40mA. To visualize proteins, gels were washed 3
times, each for 5min, with distilled water and stained with colloidal
Coomassie blue (GelCode Blue Safe Protein Stain, Thermo Fisher Sci-
entiﬁc). When necessary, proteins were identiﬁed by peptide mass
ﬁngerprinting following standard procedures.
2.4. Intervention study in piglets
Twelve pigs of the “Asturcelta” local breed, six females and six
males corresponding to four diﬀerent litters, were used in this study.
This breed was chosen because the animals are bred in a natural (semi-
extensive) system and do not receive preventive antibiotic treatment.
The day after birth, piglets were treated with 100mg of IM iron and
canines were routinely cut. Feed was oﬀered to the animals at day 20
after birth and weaning was done at the age of 40–42 days. After
weaning, pigs were housed outdoors in groups of ﬁve to seven in-
dividuals and had free access to feed (concentrate of cereals with 3%
(w/w) fat), grass and fresh water. At the age of four to ﬁve months, a
daily dose of live Lactobacillus acidophilus DSM 20079T was adminis-
tered every morning during ﬁfteen days (day 1–15). Piglets were ad-
ministrated a single and daily oral dose of 5× 1010 viable lactobacilli
dissolved in fresh water. Washing period consisted in an additional
period of seven days after discontinuation of the bacteria administra-
tion. Blood was extracted at days 1, 8, 15 and 22 from the jugular vein
in EDTA tubes. Plasma and peripheral blood mononuclear cells were
separated for further analysis.
2.5. Peripheral blood mononuclear cells (PBMCs) isolation from piglets,
healthy human donors or CD patients.
The capability of synthetic bacterial peptides to induce immune
modulation in vitro was assessed using a peripheral blood mononuclear
cells (PBMCs) model. PBMCs were isolated either from the piglet blood
samples, from the buﬀy coat of 5 healthy donors from the Community
Center for Blood and Tissues of Asturias (Oviedo, Spain) or from the CD
patient blood aliquots as previously described (Hidalgo-Cantabrana
et al., 2017).
2.6. Isolation of CD4+ T cells and naïve T cells from healthy human donors
or CD patients.
CD4+ T cells were isolated from the buﬀy coat of healthy donors
obtained from the Community Center for Blood and Tissues of Asturias
(Oviedo, Spain). In short, 5 mL of buﬀy were diluted with equal volume
of phosphate buﬀered saline (PBS) and 25 μl mL−1 of RosetteSep™
Human CD4+ T cell Enrichment Cocktail (Stemcell Technologies) was
added and incubated for 20min. Then 10mL of PBS with 2% FBS was
added to the buﬀy mixture. The 20mL buﬀy solution, containing one
part of blood and 3 parts of PBS, was added on top Ficoll-Hypaque for
gradient separation to isolate CD4+ T cells at 3100 rpm, 20min. The
CD4+ enrichment cocktail induced the precipitation of all the cells
unless the CD4+ T cells that stay on top when gradient separation is
performed. After gradient separation, CD4+ T cells were washed twice
with PBS at 1500 rpm, 5min. CD4+ cells were resuspended in 1mL of
PBS and counted in Neubauer chamber.
Naïve T cells (CD4+CD25-) were isolated from the CD4+ T cells
using the CD45RA MicroBeads (Milteny Biotec) following manufacturer
instructions.
2.7. In vitro diﬀerentiation of induced Treg (iTreg) in healthy human
donors.
The in vitro diﬀerentiation of iTreg was performed as previously
described by Fantini, Dominitzki, Rizzo, Neurath, and Becker (2007).
Brieﬂy, 24-well plate was coated with 1 μgmL−1 anti-CD3 antibody in
PBS for 2 h at 37 °C. Naïve CD4+CD25- cells were resuspended
(2×106 cells/mL) in X-Vivo15 serum free medium with antibiotics and
500 μl were added to each well, after washing the plate from the anti-
CD3 not adhered. Then, anti-CD28 antibody (2 μgml−1), TGFβ
(5 ngml−1) and IL-2 (100 Uml−1) were used for iTreg diﬀerentiation in
the presence or absent of bacterial extracts (50 μgmL−1). Cells were
incubated for 5 days at 37 °C with 5% CO2.
C. Hidalgo-Cantabrana, et al. Journal of Functional Foods 64 (2020) 103660
2
2.8. Generation of monocyte-derived DCs from human PBMCs.
Human peripheral blood mononuclear cells (PBMCs) were obtained
from standard buﬀy-coat preparations from 12 healthy blood donors
(Asturian Blood Transfusion Center, Oviedo, Spain) by centrifugation
over Ficoll-Hypaque gradients (Lymphoprep, Nycomed, Oslo, Norway).
Monocytes (CD14+ ≥95%) were isolated from previously obtained
PBMCs by positive selection using magnetic CD14 MicroBeads and
MACS system (Miltenyi). Immature DCs were obtained by culturing the
PBMC fraction in Dutch modiﬁed RPMI 1640 (Sigma-Aldrich, Dorset,
UK) containing 100 µg/mL penicillin/streptomycin, 2 mM L-glutamine,
50 mg/mL gentamycin (Sigma-Aldrich) and 10% fetal calf serum (TCS
cellworks, Buckingham, UK)] in 48 well culture dishes for 6 days (37 °C,
5% CO2, high humidity). 200 IU/ml GM-CSF and 200 IU/ml IL-4 were
used as diﬀerentiation factors. Half of the medium volume was replaced
at days 3 and 5. In day 7 MoDCs were recovered from the plates,
counted, and adjusted to a cell density of 4×106 cells mL−1. MoDC
diﬀerentiation was assessed by ﬂow cytometry by the absence of CD14
expression and the increase of the HLA-DR marker using monoclonal,
FITC and PE conjugated antibodies, respectively.
2.9. Co-cultivation of extracellular proteins and human/piglet PBMCs.
PBMCs were cultivated in round bottom 96 wells microplates using
200 μl of a 4× 106 cells mL−1 cell suspension. Extracellular proteins
were added to a ﬁnal concentration of 0.1, 1 or 10 μgmL−1, based on
previous studies of the immunomodulatory peptide STp (Bernardo
et al., 2012). For each donor positive (LPS, 1 μgmL−1 and PHA,
10 μgmL−1 in the case of piglet PBMCs) and negative controls of
PBMCs stimulation were included. Microplates were incubated for
5 days at 37 °C with 5% CO2. Finally, supernatants were recovered in
order to quantify the concentrations of the diﬀerent cytokines.
2.10. Hematological analysis and immunological phenotyping
For ﬂow cytometry analysis PBMCs were surface-stained with
Multiset CD3-FITC/CD16+56-PE/CD45-PerCP/CD19-APC Reagent (BD
Biosciences, San Jose, CA, USA), anti-CD4 (PerCP), anti-CD8 (PE or
PerCP), anti-CD45RA (FITC) (Immunostep, Salamanca, Spain), anti-
CCR7 (Alexa Fluor 647), anti-CD28 (APC-H7), anti-CD45RA (APC-H7),
anti-CD4 (PE-Cy), anti-CD27 (PE-Cy), and anti-CD3 (FITC) (BD
Biosciences). To analyze an activated phenotype, cells were stained
with anti-CD3 (APC), anti-CD8 (FITC or PE), anti-CD4 (PerCP), anti-
CD69 (FITC), anti-CD127 (PE), anti-HLA-DR (FITC), and anti-CD25
(APC) (BD Bioscience). One hundred microliters of whole blood from
each volunteer was stained with diﬀerent combinations of labelled
monoclonal antibodies for 20min at room temperature. Samples were
red-blood lysed with FACS Lysing Solution (BD Biosciences), washed in
PBS, and analyzed using CellQuest software in a FACSCanto Cytometer
(BD Biosciences). Appropriate isotype control mAbs were used for
marker settings.
2.11. Activation and proliferation assays by ﬂow cytometry
To analyze the activated phenotype, PBMCs (4× 106 cells mL−1)
were cultured in the presence and absence of anti-CD3 (1 μgmL−1)
(eBioscience), extracellular protein extract from the 20,079 strain
(DSM, 10 μgmL−1) and anti-CD3+DSM. Cells were cultured for 18 h
and then stained with anti-CD69 (FITC), anti-CD3 (PerCP), and anti-
CD4 or anti-CD8 (APC) (Immunostep) and analyzed on the cytometer.
For the proliferation assay PBMCs were resuspended in PBS at a
ﬁnal concentration of 5–10×106 cells mL−1 and incubated with
1.5 μM carboxyﬂuorescein succinimidyl ester) (CFSE, Invitrogen,
Paisley, Scotland, UK) for 10min at 37 °C before being washed twice
with RPMI 1640 medium containing 2×10−3 M L-glutamine and
HEPES. Cells were then cultured at 2×106 cells mL−1 in medium, anti-
CD3 (1 μgmL−1), Pext or anti-CD3+Pext. The proliferative responses
of CD4+ and CD8+ T-lymphocytes were analyzed on day 7 after
staining with anti-CD3 (PerCP), anti-CD8 (PE), and anti-CD4 (APC). The
cells were analyzed on a BD FACSCanto ﬂow cytometer.
2.12. Intracytoplasmic staining in human T cells
Peripheral blood mononuclear cells (4× 106 cells mL−1) were cul-
tured in the presence and absence of anti-CD3 (1 μgmL−1), DSM
(10 μgmL−1) and anti-CD3+ DSM. Frequencies of T cells with in-
tracytoplasmic production of IFN-γ, TNF, IL-17 and IL-10 after 18 h of
culture were measured. Cells were surface-stained with anti-CD3
(PerCP), anti-CD8 (PE), and anti-CD4 (APC) for 30min at room tem-
perature, lysed and ﬁxed with FACS lysing solution, permeabilized with
BD FACS Permeabilizing Solution 2 (Perm II) (BD Bioscience), and
stained with anti-IFN-γ (FITC) (eBiosciences), anti-TNF (PE) (BD
Bioscience), anti-IL-17 (APC) (Biolegend) or anti-IL-10 (Biolegend) for
30min at room temperature. Cells were washed and resuspended in 1%
paraformaldehyde until FACS analysis.
2.13. Cytokine quantiﬁcation
Cytokines were measured both in piglet plasma and in the super-
natant of cell cultures of PBMCs either extracted from human donors or
piglets. After an incubation period of 5 days, supernatant was collected
and stored at −80 °C for multiplexed cytokine analyses. In the case of
humans, the production of 18 diﬀerent cytokines was quantiﬁed using
the Th1/Th2/Th9/Th17/Th22/Treg Cytokine 18-Plex Human
ProcartaPlex™ Panel (Aﬀymetrix eBioscience, San Diego, USA) and the
Luminex® xMap Technology equipment following manufacturer’s set-
tings. In the case of piglets, 9 diﬀerent cytokines were measured
(Cytokine & Chemokine 9-Plex Porcine ProcartaPlex™ Panel 1). The
results for each cytokine were represented using box plot diagrams and
diﬀerences between peptides were statistically analysed.
2.14. RNA-seq
Fifteen micrograms of total RNA were extracted from 24 diﬀerent
moDC samples exposed or not to 1 µg/mL LPS or 10 µg/mL DSM, and
also from CD4+ cells isolated using magnetic-conjugated antibodies
from PBMCs previously incubated with anti-CD3 or anti-CD3+ 10 µg/
mL DSM. In both cases the RNeasy Mini Kit (QIAGEN) was used fol-
lowing the manufacturer’s instructions. Total mRNA was sequenced in
the facilities of GenProbio SRL (http://www.genprobio.com/) in a
HiSeq Illumina System (llumina, Inc). Preparation of the libraries, li-
gation of required adaptors and sequencing was performed according to
the manufacturer indications. Brieﬂy, about 25 million paired-end
reads of 100 nucleotides were obtained for each sample. Roughly this
represented about 2.5×109 clean bases after application of quality
ﬁltering suggested by Illumina. Filtered RNA data was exported in
FASTq format and was used as input for DEWE (http://www.sing-
group.org/dewe/). Raw data can be retrieved from the European
Nucleotide Archive (ENA): http://www.ebi.ac.uk/ena/data/view/
PRJEB31318.
2.15. Statistical analyses
All experiments were performed in independent biological quintu-
plicates. Data distribution did not follow normality, so initial compar-
isons were performed with the non-parametric Wilcoxon and Tukey
pairwise tests. Diﬀerences in the value ranks between two conditions
were assessed with the Mann-Whitney U and Wilcoxon tests for equal
medians with Monte Carlo permutations (n= 99,999) implemented in
the Past3 software v3.15 (Ryan, Hammer, & Harper, 2001). Compar-
isons with a p-value≤ 0.05 were considered statistically signiﬁcant. All
the graphics showed in this paper were obtained in R environment.
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3. Results
3.1. Eﬀect of extracellular protein extract in piglets
The probiotic eﬀect of L. acidophilus DSM 20,079 was initially
evaluated in healthy pigs administrating a daily dose of 5×1010 viable
cells during two weeks to a cohort of twelve animals (Suppl. Table 1).
Peripheral blood was extracted from the jugular vein at four diﬀerent
times spanned one week each: before starting the probiotic adminis-
tration, after 7 and 14 days of daily probiotic intake, and one week after
the end of the intervention (washing period) (Fig. 1a). Two types of
experiments were performed with the blood samples that involve (i)
cytokine quantiﬁcation in plasma and (ii) isolation of peripheral blood
mononuclear cells (PBMCs). Plasma was used for longitudinal cytokine
quantiﬁcation and PBMCs to analyze the eﬀect of two well-known sti-
mulators of the innate immune system (LPS) or the T cells (PHA). The
only cytokines presenting shifts in their plasma concentrations during
the whole trial were IL10, IL12p40 and IL8 (Supplementary Fig. 1a).
The anti-inﬂammatory IL10 cytokine showed a statistically signiﬁcant
(p < 0.028) increase whereas neither IL12p40 nor a pro-inﬂammatory
ratio (IL12p40+TNFα/IL10) returned signiﬁcant changes, although a
decreasing trend was observed for both parameters (Fig. 1b). The
PBMCs showed lower activation levels when exposed to LPS and the
same trend (also not statistically signiﬁcant) in response to PHA
(Fig. 1c, Supplementary Fig. 1b). This suggested that the tolerogenic
eﬀect induced in piglets by DSM 20079 administration was mainly due
through the action over innate immune cells.
Additionally, several L. acidophilus strains recovered from the piglets
during the trial shown an increased capacity to produce extracellular S-
layer protein A (SlpA) (Fig. 1d). For this reason, we tested the eﬀect of
extracellular proteins over PBMCs using the extracellular fraction from
the strain DSM 20079 and other two well-known probiotic strains,
Lactobacillus rhamnosus GG and Biﬁdobacterium longum subsp. longum
NCIMB8809. Principal component analysis showed that DSM20079 had
an eﬀect mostly dependent on the increased production of IL2, IL6 and
IL17A, being the production of IL2 signiﬁcantly higher than the positive
control for immunomodulation (Fig. 2, Supplementary File 1). On the
contrary, extracellular protein fraction from B. longum subsp. longum
NCIMB8809 induced almost no eﬀect on PBMC cytokine secretion when
compared to basal conditions. Proteins precipitated from the growth
medium had no eﬀect over PBMC cytokine secretion (Hidalgo-
Cantabrana et al., 2017).
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Fig. 1. Eﬀect of the administration of live Lactobacillus acidophilus DSM 20079T to healthy piglets. (a) Schematic representation of the design of the study, with a daily
administration of 5× 109 viable cells during two weeks and four sample points of blood extraction. (b) Cytokine quantiﬁcation in plasma. (c) Cytokine quantiﬁcation
in PBMCs isolated from the same animals. (d) Extracellular protein proﬁles from a L. acidophilus strain (20079-6), a 20079 derivative showing increased capacity to
produce SlpA. MM, molecular mass.
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3.2. Eﬀects of DSM20079 in healthy human donors
In order to get a deeper insight into the mechanism of action of
DSM20079 over human innate immune cells, we used the monocyte-
derived dendritic cells (MoDC) model coupled to RNA-seq, with LPS as
a control of MoDC activation. The DSM20079 strain induced notable
changes in the gene expression proﬁles of the MoDCs compared to the
eﬀect of LPS (Fig. 3a, Supplementary File 2). Namely, 1045 and 478
genes were induced by the DSM or LPS, respectively, whereas 785 and
418 genes were repressed by these molecules. The same 260 and 223
genes were induced/repressed by both compounds (Fig. 3b). Analysis of
the pathways over- or down-represented was determined as those
showing a Benjamini q-value lower than 0.001 and False Discovery
Rates lower than 0.05 after a pathway enrichment analysis using the
DAVID web tool. Over-represented pathways as aﬀected by DSM20079
included NF-kappa B, TNF, Toll-like receptor, MAPK and TNFR2 sig-
naling pathways, indicating that DSM20079 proteins are sensed
through innate immune pathways. Downregulated pathways included
mainly metabolic pathways. IL2 and its receptor on T cells CD25, are
central in the expansion of Treg cells (de la Rosa, Rutz, Dorninger, &
Scheﬀold, 2004; López et al., 2012), adding further experimental sup-
port to the immunomodulatory and tolerogenic eﬀect of DSM20079
over innate immune cells present in the gut mucosa.
3.3. Eﬀects of DSM20079 on cytokine production in immune cells from
healthy donnors
A human 18-plex cytokine array was used to assess the eﬀect of
DSM20079 and B. longum NCIMB8809 extracellular protein extracts
over T cells isolated from healthy donors. In this case, the PBMCs were
exposed to anti-CD3, an antibody which targets/activates speciﬁcally
the T cell receptor. In this scenario, DSM20079 decreased drastically
the levels of the pro-inﬂammatory cytokines IL12p40 and TNFα in-
duced by the activator, whereas the B. longum extract decreased the
levels of TNFα and IL6 (Fig. 4a; Supplementary File 3). Noteworthy,
anti-CD3 induction of IL-10 production was maintained by both strains,
which is an additional support of their regulatory eﬀect over host im-
munity. Regarding gene expression, DSM20079 induced a generalized
attenuation on the global shifts induced by the anti-CD3
(Supplementary Fig. 2a) and RNA-seq analysis revealed a drastic de-
crease in the number of genes over/under-expressed (Fig. 4b;
Supplementary File 4). The strain DSM20079 decreased the ability of
both CD4+ and CD8+ T cell populations to produce the pro-in-
ﬂammatory mediators IFNγ and TNFα which were induced by the anti-
CD3 antibody (Fig. 4c). Moreover, it had also the capability to increase
the generation of T regulatory cells in vitro (iTreg) from naïve T cells,
being these iTreg fully functional, as deduced from the decreased ability
to reduce the pro-inﬂammatory IFNγ in CD4+ cells activated with anti-
CD3 (p < 0.006) and to increase the production of IL10 and TGFβ by T
cells exposed to iTreg. However, none of these parameters showed
signiﬁcant diﬀerences when compared to the controls, although in-
creasing trends supporting the homeostatic action of DSM20079 were
observed (Supplementary Fig. 2b).
3.4. In vitro immunomodulatory action of extracellular proteins in a
Crohn’s Disease cohort
Finally, the eﬀect of DSM over the immune mediators secreted by
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PBMCs in a CrD cohort at the diagnosis time was assessed using a 18-
plex cytokine array. The proportions of diﬀerent T cell subsets were
ﬁrstly assessed using a multiset approach (Supplementary Fig. 3). When
we analyzed the major T cell subsets (CD3+, Natural Killers (NKs) and
CD19+), we did not ﬁnd diﬀerences between the control group and the
CD patients. However, when we analyzed the lymphocyte
a
b
785 260 218 1280 223 223
DSM20079 LPS DSM20079 LPS
Fig. 3. Eﬀect of DSM or LPS over gene expression in monocyte-derived dendritic cells (MoDCs). (a) Heatmap showing the gene expression proﬁles obtained after
RNASeq analysis of MoDCs exposed to DSM or LPS. (b) Venn diagrams showing the number of speciﬁc and common genes over/under-expressed by the presence of
the two compounds. In all the graphics, red color denotes basal conditions, green DSM2009 and blue LPS. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article.)
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subpopulations (Romero et al., 2007), we did ﬁnd signiﬁcant diﬀer-
ences between the CD and control groups studied, both in CD4+ and
CD8+ T cell subsets. We found for instance a very important decrease
in the global number of the circulating CD4+ T lymphocytes in CD
patients, suggesting a potential transfer of these cells to other body
locations (for instance retained in the gut mucosa). In addition, a
deeper segmentation of the CD4+ T cell subpopulations revealed that
the most diﬀerentiated populations, namely EM1, EM3, EM4 and E
were increased in CD patients. The same trend was observed in CD8+ T
cells, with an increase in the CM, EM3, pE1, pE2 subpopulations and a
very strikingly increase in the subpopulation E, the most diﬀerentiated
lymphocyte subpopulation.
The 18-plex cytokine array was applied to the study of the immune
mediators secreted by T cells. Noteworthy, IL10 levels displayed sig-
niﬁcant diﬀerences when the diﬀerent groups were compared to basal
conditions (500-fold increase). Increases in IL12p40 production in-
duced by the anti-CD3 antibody over T cells were almost abrogated by
the presence of DSM20079, although the pro-inﬂammatory ratio
(IL12p40+TNFα/IL10) was not signiﬁcantly reduced (p < 0.27)
(Fig. 5a). Other cytokines presenting increases by the presence of
DSM20079 were GM-CSF, IL1β and IL6 (Supplementary Fig. 4). Re-
garding the eﬀect over T cell populations, signiﬁcant decreases in CD4+
and CD8+ proliferation and in CD4+ and CD8+ TNFα-producing T cells
were detected with the administration of DSM20079 (Fig. 5b). Also, a
reduction in the proportion of the CD4+ IFNγ- and IL17-producing T
cells was detected for CD4+ subpopulation.
4. Discussion
In this paper, we have analyzed the immunomodulatory eﬀect of a
daily intake of living L. acidophilus DSM 20079T cells in an animal
model, in which an anti-inﬂammatory and homeostatic eﬀect was ob-
served analyzing both plasma and PBMCs exposed to diﬀerent pro-in-
ﬂammatory stimuli. In order to go deeper into the molecular me-
chanism of action, we focused in the extracellular protein fraction. In a
previous study, we have already shown that diﬀerent fractions of
DSM20079 induced a Th17 response and therefore pro-inﬂammatory
polarization on PBMCs isolated from healthy human donors (Hidalgo-
Cantabrana et al., 2017). As this in vitro study did not include the ex-
tracellular protein fraction, we hypothesized whether these molecules
were inducing the homeostatic eﬀects observed in our in vivo experi-
ment using healthy piglets. For this purpose we used PBMCs and MoDCs
isolated from healthy donors, and again the anti-inﬂammatory eﬀect of
the extracellular proteins prompted up. For this reason, we studied in
last place the eﬀect of the extracellular proteins over PBMCs and T cells
isolated from Crohn’s patients, which show a basal proinﬂammatory
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Fig. 4. Eﬀect of DSM over the production of cytokines in PBMCs obtained from healthy donors. (a) Signiﬁcant changes in IL12p40, IL10, IL6 and TNFα con-
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cytokine proﬁle (Barratt-Stopper, Nemeth, & Rolandelli, 2016), and in
which we conﬁrmed the anti-inﬂammatory eﬀect of the extracellular
protein fraction of L. acidophilus. Over-representation of im-
munomodulatory pathways induced by DSM20079 in human MoDCs
isolated from healthy donnors, as well as the cytokine proﬁles in re-
sponse to pro-inﬂammatory signals, supported the hypothesis that
DSM20079 elicited its homeostatic eﬀects through the action of their
extracellular proteins over innate immune cells. In the case of
DSM20079, the extracellular protein fraction is mainly composed of
SlpA and, in a much lesser extent, of at least two diﬀerent aggregation-
promoting factors (Sánchez, Ruiz, Suárez, De los Reyes-Gavilán, &
Margolles, 2011). In this sense it has been already established that S-
layer interacts with speciﬁc receptors on the dendritic cell surface,
triggering and repressing the production of IL10 and IL12, respectively
(Konstantinov et al., 2008; Lightfoot et al., 2015). Our transcriptomic
results support this point, as it is clear that extracellular proteins from L.
acidophilus DSM 20079 are sensed through innate immune pathways.
As DSM20079 appeared to mitigate the pro-inﬂammatory response
elicited either by LPS or anti-CD3 in human PBMCs/T cells, we
underwent an in vitro approach in which PBMCs isolated from Crohn’s
Disease patients were obtained at the diagnosis time, being this im-
portant as none of these patients had been treated for the illness before.
This cohort consisted of 15 individuals, with an average age of
41.3 ± 12.9 years, and a sex distribution of 8 men and 7 women
(Suppl. Table 2). Our main question was whether DSM20079 might be
eﬀective helping in recovering the balance between pro- and anti-in-
ﬂammatory signals in an IBD population. Analysis of the CD4+ T cell
subpopulations revealed that memory populations, namely EM1, EM3,
EM4 and E were increased in CrD patients. The same trend was ob-
served in CD8+ T cells, with a very strikingly increase in the sub-
population E, the most diﬀerentiated lymphocyte subpopulation. Our
CrD cohort displayed a much higher degree of diﬀerentiated lympho-
cytes than the control group matched by sex and age, which was in
agreement with previous ﬁndings by other research groups (Dai et al.,
2017; Dai et al., 2017; Yokoyama et al., 2011). The anti-inﬂammatory
eﬀect of DSM 20079 was patent, with signiﬁcant increases in the anti-
inﬂammatory IL10 production, and decreases in the pro-inﬂammatory
IL12 production by PBMCs exposed to these extracellular proteins.
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Fig. 5. Eﬀect of DSM over cytokine production by PBMCs obtained from Crohn’s Disease patients (n= 15). (a) Concentrations of IL10, IL12p40 and the pro-
inﬂammatory ratio (IL12p40+TNFα)/IL10 as aﬀected by the presence of LPS, αCD3, DSM and DSM+αCD3. (b) Percentage of proliferative/CD69+ CD4+ and
CD8+ T cells and percentage of these cells producing TNFα, IFNγ, IL17 and IL10 in response to the same compounds.
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In conclusion, DSM 20079 induced regulatory and anti-in-
ﬂammatory eﬀects in both healthy piglets/humans, attenuated in vitro
CD4+/CD8+ activity and the production of pro-inﬂammatory media-
tors in PBMCs isolated from both healthy donors and CrD patients, in
response to pro-inﬂammatory stimuli. The mechanism of action of DSM
20079 over MoDCs showed activation of innate immune pathways, and
downregulation of the signalization pathways activated by the anti-CD3
activator in human T cells. Finally, the concentration of IL10 by PBMCs
from CrD patients increased in response to DSM20079. This work opens
new avenues to clinical trials in which the extracellular protein fraction
may be used in intervention studies were the permeability in the human
gut mucosa is compromised, overcoming the bacterial viability and
health risks concerns associated to the use of living bacteria in this
critical situation.
Ethics statement
All procedures were approved by the Animal research ethics
Committee of Principado de Asturias, Spain, (reference number PROAE-
12/2018). Experiments were conducted in accordance with the current
Spanish and European legal requirements and guidelines regarding
experimentation and Animal Welfare.
Ethics approval for this study (reference code AGL2013-44039-R
and PS2016) was obtained from the Regional Ethics Committee for
Clinical Research in compliance with the Declaration of Helsinki.
Samples used in this study were obtained from anonymous donors of
the regional blood donation system and from a cohort of Crohn’s
Disease patients.
Acknowledgements
Our work is supported by the Spanish “Programa Estatal de
Investigación, Desarrollo e Inovación Orientada a los Retos de la
Sociedad” (grant AGL2016-78311-R); the Asociación Española Contra
el Cancer (“Obtención de péptidos bioactivos contra el Cáncer Colo-
Rectal a partir de secuencias genéticas de microbiomas intestinales”,
Grant PS-2016) and by the Asturias Regional Plan I+D+i for research
groups (FYCYT-IDI/2018/000236). This study was also supported by
the Portuguese Foundation for Science and Technology (FCT) under the
scope of the strategic funding of UID/BIO/04469/2013 unit and
COMPETE 2020 (POCI-01-0145-FEDER006684). SING group thanks
CITI (Centro de Investigación, Transferencia e Innovación) from
University of Vigo for hosting its IT infrastructure. LJR was supported
by the Principado de Asturias, PCTI 2018–2020 (GRUPIN: IDI2018-
000237) and FEDER. This work was partially supported by the
Consellería de Educación, Universidades e Formación Profesional
(Xunta de Galicia) under the scope of the strategic funding of
ED431C2018/55-GRC Competitive Reference Group.
Declaration of Competing Interest
Abelardo Margolles, Borja Sánchez and Claudio Hidalgo are mem-
bers of the scientiﬁc advisory board of Microviable Therapeutics SL.
Appendix A. Supplementary material
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.jﬀ.2019.103660.
References
Barratt-Stopper, P., Nemeth, Z., & Rolandelli, R. (2016). P-159 Crohn’s disease and ul-
cerative colitis show unique cytokine proﬁles. Inﬂammatory Bowel Diseases. https://
doi.org/10.1097/01.mib.0000480254.25267.ﬀ.
Bernardo, D., Sánchez, B., Al-Hassi, H. O., Mann, E. R., Urdaci, M. C., Knight, S. C., &
Margolles, A. (2012). Microbiota/host crosstalk biomarkers: Regulatory response of
human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted
peptide. PLoS ONE, 7(5), 1–8. https://doi.org/10.1371/journal.pone.0036262.
Call, E. K., Goh, Y. J., Selle, K., Klaenhammer, T. R., & O’Flaherty, S. (2015). Sortase-
deﬁcient lactobacilli: Eﬀect on immunomodulation and gut retention. Microbiology
(United Kingdom), 161(2), 311–321. https://doi.org/10.1099/mic.0.000007.
Chaparro, M., Barreiro-de Acosta, M., Benítez, J. M., Cabriada, J. L., Casanova, M. J.,
Ceballos, D., ... Gisbert, J. P. (2019). EpidemIBD: Rationale and design of a large-
scale epidemiological study of inﬂammatory bowel disease in Spain. Therapeutic
Advances in Gastroenterology. https://doi.org/10.1177/1756284819847034.
Dai, S.-X., Gu, H.-X., Lin, Q.-Y., Wu, Y.-K., Wang, X.-Y., Huang, S.-Z., ... Sha, W.-H.
(2017a). Decreased CD8+CD28+/CD8+CD28- T cell ratio can sensitively predict
poor outcome for patients with complicated Crohn disease. Medicine, 96(26), e7247.
https://doi.org/10.1097/MD.0000000000007247.
Dai, S., Gu, H., Lin, Q., Huang, S., Xing, T., Zhang, Q., ... Sha, W. (2017b). CD8 + CD28 +
/CD8 + CD28 − T cell equilibrium can predict the active stage for patients with
inﬂammatory bowel disease. Clinics and Research in Hepatology and Gastroenterology,
41(6), 693–702. https://doi.org/10.1016/j.clinre.2017.03.009.
de la Rosa, M., Rutz, S., Dorninger, H., & Scheﬀold, A. (2004). Interleukin-2 is essential
for CD4+CD25+ regulatory T cell function. European Journal of Immunology, 34(9),
2480–2488. https://doi.org/10.1002/eji.200425274.
Fantini, M. C., Dominitzki, S., Rizzo, A., Neurath, M. F., & Becker, C. (2007). In vitro
generation of CD4+CD25+ regulatory cells from murine naive T cells. Nature
Protocols, 2(7), 1789–1794. https://doi.org/10.1038/nprot.2007.258.
Goh, Y. J., & Klaenhammer, T. R. (2010). Functional roles of aggregation-promoting-like
factor in stress tolerance and adherence of lactobacillus acidophilus NCFM. Applied
and Environmental Microbiology, 76(15), 5005–5012. https://doi.org/10.1128/AEM.
00030-10.
Hidalgo-Cantabrana, C., Moro-García, M. A., Blanco-Míguez, A., Fdez-Riverola, F.,
Lourenço, A., Alonso-Arias, R., & Sánchez, B. (2017). In silico screening of the human
gut metaproteome identiﬁes Th17-promoting peptides encrypted in proteins of
commensal bacteria. Frontiers in Microbiology, 8(SEP), https://doi.org/10.3389/
fmicb.2017.01726.
Johnson, B. R., Hymes, J., Sanozky-Dawes, R., Henriksen, E. D., Barrangou, R., &
Klaenhammer, T. R. (2016). Conserved S-layer-associated proteins revealed by exo-
proteomic survey of S-layer-forming lactobacilli. Applied and Environmental
Microbiology, 82(1), 134–145. https://doi.org/10.1128/AEM.01968-15.
Konstantinov, S. R., Smidt, H., de Vos, W. M., Bruijns, S. C. M., Singh, S. K., Valence, F., ...
van Kooyk, Y. (2008). S layer protein A of Lactobacillus acidophilus NCFM regulates
immature dendritic cell and T cell functions. Proceedings of the National Academy of
Sciences, 105(49), 19474–19479. https://doi.org/10.1073/pnas.0810305105.
Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of
bacteriophage T4. Nature, 227(5259), 680–685. https://doi.org/10.1038/227680a0.
Lebeer, S., Vanderleyden, J., & De Keersmaecker, S. C. J. (2010). Host interactions of
probiotic bacterial surface molecules: Comparison with commensals and pathogens.
Nature Reviews Microbiology, 8(3), 171–184. https://doi.org/10.1038/nrmicro2297.
Lightfoot, Y. L., Selle, K., Yang, T., Goh, Y. J., Sahay, B., Zadeh, M., ... Mohamadzadeh, M.
(2015). SIGNR 3 -dependent immune regulation by Lactobacillus acidophilus surface
layer protein A in colitis. Embo Journal, 34(November), 1–16. https://doi.org/10.
15252/embj.201490296.
López, P., González-Rodríguez, I., Sánchez, B., Gueimonde, M., Margolles, A., & Suárez, A.
(2012). Treg-inducing membrane vesicles from Biﬁdobacterium biﬁdum LMG13195
as potential adjuvants in immunotherapy. Vaccine, 30(5), 825–829. https://doi.org/
10.1016/j.vaccine.2011.11.115.
Maslowski, K. M., Vieira, A. T., Ng, A., Kranich, J., Sierro, F., Di, Yu., ... MacKay, C. R.
(2009). Regulation of inﬂammatory responses by gut microbiota and chemoattractant
receptor GPR43. Nature, 461(7268), 1282–1286. https://doi.org/10.1038/
nature08530.
Mohamadzadeh, M., Pfeiler, E. A., Brown, J. B., Zadeh, M., Gramarossa, M., Managlia, E.,
... Klaenhammer, T. R. (2011). Regulation of induced colonic inﬂammation by
Lactobacillus acidophilus deﬁcient in lipoteichoic acid. Proceedings of the National
Academy of Sciences, 108(Supplement_1), 4623–4630. https://doi.org/10.1073/pnas.
1005066107.
O’Flaherty, S. J., & Klaenhammer, T. R. (2010). Functional and phenotypic character-
ization of a protein from Lactobacillus acidophilus involved in cell morphology, stress
tolerance and adherence to intestinal cells. Microbiology, 156(11), 3360–3367.
https://doi.org/10.1099/mic.0.043158-0.
Romero, P., Zippelius, A., Kurth, I., Pittet, M. J., Touvrey, C., Iancu, E. M., ... Rufer, N.
(2007). Four functionally distinct populations of human eﬀector-memory CD8 + T
lymphocytes. The Journal of Immunology. https://doi.org/10.4049/jimmunol.178.7.
4112.
Ryan, P. D., Hammer, Ø., & Harper, D. A. (2001). Past: Paleontological statistics software
package for education and data analysis. Palaeontologia Electronica 178kb. T.
Harper. Geological Museum. Doi: 10.1016/j.bcp.2008.05.025.
Sánchez, B., Chaignepain, S., Schmitter, J. M., & Urdaci, M. C. (2009). A method for the
identiﬁcation of proteins secreted by lactic acid bacteria grown in complex media.
FEMS Microbiology Letters, 295(2), 226–229. https://doi.org/10.1111/j.1574-6968.
2009.01599.x.
Sánchez, B., Ruiz, L., Suárez, A., De los Reyes-Gavilán, C. G., & Margolles, A. (2011).
Human cecum content modulates production of extracellular proteins by food and
probiotic bacteria. FEMS Microbiology Letters, 324(2), 189–194. https://doi.org/10.
1111/j.1574-6968.2011.02408.x.
Sanders, M. E., & Klaenhammer, T. R. (2001). Invited review: The scientiﬁc basis of
Lactobacillus acidophilus NCFM functionality as a probiotic. Journal of Dairy Science,
84(2), 319–331. https://doi.org/10.3168/jds.S0022-0302(01)74481-5.
Walter, J., & Ley, R. (2011). The human gut microbiome: Ecology and recent evolutionary
changes. Annual Review of Microbiology, 65(1), 411–429. https://doi.org/10.1146/
annurev-micro-090110-102830.
C. Hidalgo-Cantabrana, et al. Journal of Functional Foods 64 (2020) 103660
9
Willing, B., Halfvarson, J., Dicksved, J., Rosenquist, M., Järnerot, G., Engstrand, L., ...
Jansson, J. K. (2009). Twin studies reveal speciﬁc imbalances in the mucosa-asso-
ciated microbiota of patients with ileal Crohn’s disease. Inﬂammatory Bowel Diseases,
15(5), 653–660. https://doi.org/10.1002/ibd.20783.
Yokoyama, Y., Fukunaga, K., Ikeuchi, H., Kamikozuru, K., Hida, N., Ohda, Y., ...
Matsumoto, T. (2011). The CD4+CD28null and the regulatory CD4+CD25High T-
cell phenotypes in patients with ulcerative colitis during active and quiescent disease,
and following colectomy. Cytokine, 56(2), 466–470. https://doi.org/10.1016/j.cyto.
2011.06.021.
C. Hidalgo-Cantabrana, et al. Journal of Functional Foods 64 (2020) 103660
10
